ClinConnect ClinConnect Logo
Search / Trial NCT07147218

Accelerated TMS for MDD

Launched by NEURONETICS ·

Trial Information

Current as of September 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called accelerated Transcranial Magnetic Stimulation (TMS) for people with Major Depressive Disorder (MDD), which is a type of depression. TMS is a non-invasive procedure that uses magnetic pulses to stimulate certain areas of the brain that are involved in mood regulation. This study aims to see if giving these treatments more quickly than usual is safe and effective in helping reduce depression symptoms.

The trial is open to adults of all genders who are between the ages of 18 and 78 and have been diagnosed with Major Depressive Disorder. If you join, you can expect to receive several TMS sessions over a shorter period than typical treatment schedules. Because this study is still recruiting participants, it’s a good opportunity for those interested in trying a new approach to managing depression. The researchers will closely monitor your progress to understand how well this faster treatment works and if it’s safe.

Gender

ALL

Eligibility criteria

About Neuronetics

Neuronetics, a leading medical technology company, specializes in developing non-invasive solutions for neuropsychiatric disorders. With a focus on innovative therapies, Neuronetics is dedicated to advancing the field of neuromodulation through its flagship product, the NeuroStar® Advanced Therapy System, which utilizes Transcranial Magnetic Stimulation (TMS) to treat major depressive disorder. Committed to improving patient outcomes and enhancing the quality of life for individuals suffering from mental health conditions, Neuronetics actively engages in clinical trials to evaluate the efficacy and safety of its therapies, fostering a robust pipeline of research that underpins its mission to transform mental health treatment.

Locations

Patients applied

0 patients applied

Trial Officials

Eleanor Cole, PhD

Study Director

Neuronetics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported